My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 150

    1.

    Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy.

    Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H; ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group.

    Part Fibre Toxicol. 2005 Oct 6;2:8.PMID: 16209704 [PubMed]Related articlesFree article

    2.

    Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.

    Warheit DB, Borm PJ, Hennes C, Lademann J.

    Inhal Toxicol. 2007 Jun;19(8):631-43.PMID: 17510836 [PubMed - indexed for MEDLINE]Related articles

    3.

    Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

    EFSA GMO Panel Working Group on Animal Feeding Trials.

    Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. Epub 2008 Feb 13. Review.PMID: 18328408 [PubMed - indexed for MEDLINE]Related articles

    5.

    Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.

    Thybaud V, Aardema M, Clements J, Dearfield K, Galloway S, Hayashi M, Jacobson-Kram D, Kirkland D, MacGregor JT, Marzin D, Ohyama W, Schuler M, Suzuki H, Zeiger E; Expert Working Group on Hazard Identification and Risk Assessment in Relation to In Vitro Testing.

    Mutat Res. 2007 Feb 3;627(1):41-58. Epub 2006 Nov 27.PMID: 17126066 [PubMed - indexed for MEDLINE]Related articles

    6.

    Strategy for genotoxicity testing--metabolic considerations.

    Ku WW, Bigger A, Brambilla G, Glatt H, Gocke E, Guzzie PJ, Hakura A, Honma M, Martus HJ, Obach RS, Roberts S; Strategy Expert Group, IWGT.

    Mutat Res. 2007 Feb 3;627(1):59-77. Epub 2006 Dec 1.PMID: 17141553 [PubMed - indexed for MEDLINE]Related articles

    8.

    How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.

    Kirkland D, Pfuhler S, Tweats D, Aardema M, Corvi R, Darroudi F, Elhajouji A, Glatt H, Hastwell P, Hayashi M, Kasper P, Kirchner S, Lynch A, Marzin D, Maurici D, Meunier JR, Müller L, Nohynek G, Parry J, Parry E, Thybaud V, Tice R, van Benthem J, Vanparys P, White P.

    Mutat Res. 2007 Mar 30;628(1):31-55. Epub 2007 Jan 13.PMID: 17293159 [PubMed - indexed for MEDLINE]Related articles

    10.

    Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.

    Sayes CM, Reed KL, Warheit DB.

    Toxicol Sci. 2007 May;97(1):163-80. Epub 2007 Feb 14.PMID: 17301066 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique.

    Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM.

    Toxicol Sci. 2008 Feb;101(2):239-53. Epub 2007 Sep 13.PMID: 17872897 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management.

    Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM.

    Toxicol Lett. 2007 Jul 10;171(3):99-110. Epub 2007 Apr 27.PMID: 17566673 [PubMed - indexed for MEDLINE]Related articles

    13.

    Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers.

    Simeonova PP, Erdely A.

    Inhal Toxicol. 2009 Jul;21 Suppl 1:68-73.PMID: 19558236 [PubMed - indexed for MEDLINE]Related articles

    15.

    Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions.

    Stone V, Johnston H, Clift MJ.

    IEEE Trans Nanobioscience. 2007 Dec;6(4):331-40. Review.PMID: 18217626 [PubMed - indexed for MEDLINE]Related articles

    17.

    The potential risks of nanomaterials: a review carried out for ECETOC.

    Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutmann J, Warheit D, Oberdorster E.

    Part Fibre Toxicol. 2006 Aug 14;3:11.PMID: 16907977 [PubMed]Related articlesFree article

    19.

    Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs).

    O'Connor JC, Cook JC, Marty MS, Davis LG, Kaplan AM, Carney EW.

    Crit Rev Toxicol. 2002;32(6):521-49. Review.PMID: 12487364 [PubMed - indexed for MEDLINE]Related articles

    20.

    Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group.

    Moser VC, Walls I, Zoetis T.

    Int J Toxicol. 2005 Mar-Apr;24(2):87-94.PMID: 16036767 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk